Benin Management lowered its stake in shares of Medtronic PLC (NYSE:MDT) by 10.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 8,650 shares of the medical technology company’s stock after selling 1,000 shares during the period. Benin Management’s holdings in Medtronic PLC were worth $665,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the stock. Crow Point Partners increased its position in shares of Medtronic PLC by 26.7% in the third quarter. Crow Point Partners now owns 545 shares of the medical technology company’s stock valued at $36,000 after buying an additional 115 shares during the last quarter. J. Goldman & Company purchased a new position in shares of Medtronic PLC during the third quarter valued at approximately $6,821,000. Vontobel Asset Management increased its position in shares of Medtronic PLC by 4.1% in the fourth quarter. Vontobel Asset Management now owns 1,915,494 shares of the medical technology company’s stock valued at $154,575,000 after buying an additional 74,733 shares during the last quarter. EQIS Capital Management increased its position in shares of Medtronic PLC by 651.1% in the fourth quarter. EQIS Capital Management now owns 15,292 shares of the medical technology company’s stock valued at $1,176,000 after buying an additional 13,256 shares during the last quarter. Finally, MUFG Americas increased its position in shares of Medtronic PLC by 7.6% in the third quarter. MUFG Americas now owns 144,758 shares of the medical technology company’s stock valued at $9,691,000 after buying an additional 10,256 shares during the last quarter.

Medtronic PLC (NYSE:MDT) traded down 0.29% on Monday, hitting $75.70. 5,912,308 shares of the company’s stock were exchanged. Medtronic PLC has a 12-month low of $55.54 and a 12-month high of $79.50. The company’s 50-day moving average price is $76.36 and its 200-day moving average price is $74.52. The company has a market cap of $106.45 billion and a PE ratio of 43.26.

Medtronic PLC (NYSE:MDT) last announced its quarterly earnings results on Thursday, December 3rd. The medical technology company reported $1.03 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.03. The company had revenue of $7.10 million for the quarter. During the same period in the previous year, the company posted $0.96 EPS. Medtronic PLC’s revenue was up 61.7% on a year-over-year basis. Analysts forecast that Medtronic PLC will post $4.38 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, January 15th. Shareholders of record on Thursday, December 24th were given a dividend of $0.38 per share. This represents a $1.52 dividend on an annualized basis and a dividend yield of 2.01%. The ex-dividend date was Tuesday, December 22nd. This is a positive change from Medtronic PLC’s previous quarterly dividend of $0.26.

MDT has been the topic of several analyst reports. BTIG Research reiterated a “buy” rating and set a $84.00 price target on shares of Medtronic PLC in a report on Thursday, November 12th. Jefferies Group upped their price target on shares of Medtronic PLC from $85.00 to $88.00 and gave the company a “buy” rating in a report on Friday, December 4th. Deutsche Bank reiterated a “buy” rating on shares of Medtronic PLC in a report on Thursday, October 15th. Evercore ISI upgraded shares of Medtronic PLC from a “hold” rating to a “buy” rating and upped their price target for the company from $70.94 to $80.00 in a report on Thursday, October 8th. Finally, Zacks Investment Research upgraded shares of Medtronic PLC from a “hold” rating to a “buy” rating and set a $88.00 price target on the stock in a report on Monday, December 7th. Four analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the stock. Medtronic PLC currently has a consensus rating of “Buy” and a consensus price target of $86.13.

In related news, EVP Bryan C. Hanson sold 5,000 shares of Medtronic PLC stock in a transaction that occurred on Friday, January 8th. The shares were sold at an average price of $75.00, for a total value of $375,000.00. Following the completion of the transaction, the executive vice president now owns 106,514 shares in the company, valued at $7,988,550. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Richard Kuntz sold 13,715 shares of Medtronic PLC stock in a transaction that occurred on Friday, December 4th. The shares were sold at an average price of $78.06, for a total transaction of $1,070,592.90. Following the completion of the transaction, the vice president now owns 108,086 shares of the company’s stock, valued at approximately $8,437,193.16. The disclosure for this sale can be found here.

Medtronic plc (NYSE:MDT) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.

12 Month Chart for NYSE:MDT

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.